ATTGENO
AttgeNO is a pharmaceutical company developing treatments for acute life-threatening conditions.
ATTGENO
Industry:
B2B Biotechnology
Founded:
2005-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Total Employee:
1+
Status:
Active
Total Funding:
30 M SEK
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Current Employees Featured
Founder
Investors List
Hadean Ventures
Hadean Ventures investment in Venture Round - AttgeNO
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-08 | Attgeno Appoints Björn Westberg as CFO |